MiMedx Group, Inc. (MDXG) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $4.76 (+2.69%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 15, 2024 | Anthony Petrone | Mizuho Securities | $16.00 | +235.8% |
| Jul 2, 2024 | Ross Osborn | Cantor Fitzgerald | $11.00 | +130.8% |
| Apr 29, 2024 | Brooks O'Neil | Lake Street | $12.00 | +151.8% |
Top Analysts Covering MDXG
MDXG vs Sector & Market
| Metric | MDXG | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.26 | 2.42 |
| Analyst Count | 5 | 8 | 18 |
| Target Upside | +67.7% | +16187.2% | +19.5% |
| P/E Ratio | 23.31 | 3.77 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $274M | $314M | $355M | 4 |
| 2027-03-31 | $70M | $77M | $81M | 1 |
| 2027-06-30 | $76M | $84M | $89M | 2 |
| 2027-09-30 | $84M | $93M | $98M | 2 |
| 2027-12-31 | $92M | $102M | $108M | 1 |
| 2028-03-31 | $75M | $83M | $88M | 1 |
| 2028-06-30 | $79M | $88M | $92M | 1 |
| 2028-09-30 | $84M | $93M | $98M | 1 |
| 2028-12-31 | $88M | $97M | $103M | 1 |
| 2029-12-31 | $397M | $461M | $518M | 1 |
| 2030-12-31 | $446M | $518M | $582M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.09 | $0.08 | $0.16 | 3 |
| 2027-03-31 | $0.02 | $0.03 | $0.03 | 1 |
| 2027-06-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2027-09-30 | $0.06 | $0.06 | $0.07 | 1 |
| 2027-12-31 | $0.08 | $0.09 | $0.09 | 1 |
| 2028-03-31 | $0.02 | $0.02 | $0.02 | 1 |
| 2028-06-30 | $0.03 | $0.04 | $0.04 | 1 |
| 2028-09-30 | $0.05 | $0.06 | $0.06 | 1 |
| 2028-12-31 | $0.05 | $0.06 | $0.06 | 1 |
| 2029-12-31 | $0.30 | $0.36 | $0.42 | 1 |
| 2030-12-31 | $0.36 | $0.44 | $0.51 | 1 |
Frequently Asked Questions
What is the analyst consensus for MDXG?
The consensus among 5 analysts covering MiMedx Group, Inc. (MDXG) is Buy with an average price target of $8.50.
What is the highest price target for MDXG?
The highest price target for MDXG is $16.00, set by Anthony Petrone at Mizuho Securities on 2024-11-15.
What is the lowest price target for MDXG?
The lowest price target for MDXG is $11.00, set by Ross Osborn at Cantor Fitzgerald on 2024-07-02.
How many analysts cover MDXG?
5 analysts have issued ratings for MiMedx Group, Inc. in the past 12 months.
Is MDXG a buy or sell right now?
Based on 5 analyst ratings, MDXG has a consensus rating of Buy (2.00/5) with a +67.7% upside to the consensus target of $8.50.
What are the earnings estimates for MDXG?
Analysts estimate MDXG will report EPS of $0.08 for the period ending 2026-12-31, with revenue estimated at $314M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.